|Bid||0.00 x 800|
|Ask||220.10 x 800|
|Day's Range||211.22 - 215.47|
|52 Week Range||204.86 - 219.41|
|PE Ratio (TTM)||38.23|
|Earnings Date||Jul 24, 2018 - Jul 30, 2018|
|Forward Dividend & Yield||0.68 (0.31%)|
|1y Target Est||245.47|
Successive product launches and a marked progress in precision medicine initiatives boost Thermo Fisher's (TMO) performance.
Two members of Congress are urging the Commerce Department to consider toughening export controls on U.S. companies whose technologies they say are being used for state surveillance of citizens in China that enables human rights abuses. Mr. Rubio and Mr. Smith wrote that they had particular concerns about the use of U.S. technology in policing the country’s restive Xinjiang province, where police have rolled out one of the most extensive state surveillance programs ever built.
Thermo Fisher Scientific Inc (NYSE:TMO) trades with a trailing P/E of 38.2x, which is lower than the industry average of 38.3x. While this makes TMO appear like a great stockRead More...
LONDON, UK / ACCESSWIRE / May 11, 2018 / If you want access to our free earnings report on Thermo Fisher Scientific Inc. (NYSE: TMO), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=TMO. Thermo Fisher Scientific reported its first quarter fiscal 2018 operating and financial results on April 25, 2018. Additionally, the Company raised its revenue and earnings guidance for FY18.
WALTHAM, Mass. , May 9, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper , president and chief executive officer, will ...
Thermo Fisher Scientific Inc (NYSE:TMO) received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to $219.53 at one point, andRead More...
NEW YORK, May 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Kinder ...
(Continued from Prior Part)ABT’s Medical Device business In 1Q18, Abbott Laboratories (ABT) registered sales of $7.4 billion, representing YoY (year-over-year) growth of ~16.7%. The company’s Medical Device segment registered strong growth and contributed ~37.0% to the company’s total sales, the highest of all four of its segments. ABT’s Medical Device segment sales came in at ~$2.7 billion in 1Q18. On a reported basis, the segment’s sales growth was ~14.6% on a YoY basis. However, on an organic basis, the segment’s sales increased ~9.4%. ...
Durham-based solid-state cooling specialist Phononic has sealed an exclusive new deal with Thermo Fisher Scientific.
WALTHAM, Mass. , April 30, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2018 Analyst Meeting on Wednesday, May 23 ...
In this final part of the series, we’ll take a look at analyst recommendations and target prices for Thermo Fisher Scientific (TMO) stock for the next 12 months.
In Thermo Fisher Scientific’s (TMO) earnings announcement on April 25, it provided guidance for fiscal 2018. It raised its sales and earnings guidance on the back of strong 1Q18 operational performance, acquisition benefits, and a favorable foreign exchange. The updated guidance represents a potential sales growth of 13%–14%.
Thermo Fisher Scientific (TMO) released its 1Q18 earnings results on April 25, 2018. It registered robust sales, exceeding estimates. It posted net income of $579 million, or $1.43 per share, registering YoY (year-over-year) growth of ~5%. Its adjusted EPS (earnings per share) was $2.50, representing YoY growth of ~20% and coming in ahead of analysts’ estimate of $2.40.
On April 25, Thermo Fisher Scientific (TMO) announced its earnings results for 1Q18, which ended on March 31. Its revenues grew ~23% to ~$5.9 billion YoY (year-over-year). The sales results came in ahead of analysts’ estimate of ~$5.6 billion.
Thermo Fisher's (TMO) performance in Q1 benefits from a series of product launches alongside a major progress in precision medicine initiatives.
NEW YORK, NY / ACCESSWIRE / April 25, 2018 / Thermo Fisher Scientific Inc. (NYSE: TMO ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 25, 2018 at 8:30:00 AM Eastern ...
On a per-share basis, the Waltham, Massachusetts-based company said it had net income of $1.43. Earnings, adjusted for one-time gains and costs, were $2.50 per share. The results beat Wall Street expectations. ...
Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported higher-than-expected first-quarter profit and revenue on Wednesday, and raised its full-year forecast to reflect ...
WALTHAM, Mass. , April 25, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 31, ...
Let's take a look at the factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical universe.
Yahoo Finance's Alexis Christoforous and Jared Blikre break down the latest market action after Boeing reported first quarter earnings, beating estimates and raising full year guidance.